The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.05
Bid: 1.00
Ask: 1.10
Change: 0.00 (0.00%)
Spread: 0.10 (10.00%)
Open: 1.05
High: 1.05
Low: 1.05
Prev. Close: 1.05
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Finance Director

15 Apr 2014 09:17

RNS Number : 8488E
Microsaic Systems plc
15 April 2014
 



Microsaic Systems plc

("Microsaic" or the "Company")

 

Appointment of Andrew Darby as Finance Director

 

15 April 2014: Microsaic Systems plc (AIM: MSYS), the developer of miniaturised chip-based scientific instruments, is delighted to announce the appointment of Andrew Darby as Finance Director. Andrew will replace Malcolm Bateman who is stepping down from the Company and Board after eight years with the Company to focus on a portfolio of other business and charitable interests. Malcolm will continue as consultant to Microsaic for a short period to ensure an orderly transition. Andrew is due to be appointed to the Board of Microsaic on 16 April 2014.

 

Andrew Darby, aged 51, has over 17 years of experience in senior finance, strategic and operational roles within quoted companies in the information technology sector. He joins Microsaic from Active Risk Group plc, a former AIM-listed company specialising in enterprise risk management software solutions, where he spent seven years as Chief Operations Officer and Chief Financial Officer until its successful sale to Sword Group SE in August 2013. Prior to joining Active Risk, Andrew held several senior finance and operational positions with Misys plc, a FTSE250 banking and capital markets software firm, most recently as Finance Director, Banking Division Business Units. Prior to Misys, Andrew was Financial Controller for Generali SpA, the global financial services firm. He qualified as a Chartered Accountant with Coopers & Lybrand (now PriceWaterhouseCoopers) in 1990 and graduated with an MA (Hons) in Classics from the University of Cambridge.

 

Commenting on the appointment, Colin Jump, Chief Executive of Microsaic Systems plc, said:

 

"I am delighted to welcome Andrew to the Company as our new Finance Director. Andrew brings valuable and relevant experience to Microsaic from many years working in senior positions at fast-growing companies that are leaders in their field. His experience with quoted companies will also be important as the Company grows and looks to enhance its relationships with investors and analysts. I am confident that Andrew will make a great contribution to Microsaic in the exciting years ahead. I would also like to thank Malcolm Bateman for his work and dedication to the Company over the last eight years and wish him well with his future career."

 

Andrew Darby added:

 

"I am excited to be joining Microsaic at this time in its development and to have the opportunity to help drive this innovative business forward. Microsaic has a unique proposition in the analytical instrumentation sector and is well positioned to capitalise on the potential of its revolutionary miniaturised mass-spec technology. I look forward to contributing to the translation of this potential into real value for our shareholders."

 

It is anticipated that the preliminary results for the year ended 31 December 2013 will be released on 30 April 2014.

 

The following information is required to be disclosed pursuant to paragraph (g) of Schedule 2 of the AIM Rules for Companies:

 

Current Directorships:

 

None

 

Past Directorships in the last five years:

 

Active Risk Group plc

Active Risk Ltd

Active Risk Inc

Active Risk Pty Ltd

Line International Ltd

 

 

Contacts

 

Microsaic Systems

Colin Jump, CEO

Via Citigate Dewe Rogerson

 

Numis Securities Limited

Stuart Skinner (Nominated Adviser)

James Serjeant (Broker)

 

+44 (0)20 7260 1000

 

Citigate Dewe Rogerson (Financial PR)

Mark Swallow, Malcolm Robertson, Chris Gardner

 

+44 (0)20 7282 2948/2867/2995

 

 

Conscience Creative (Trade PR)

Reita Smith

 

+44 (0)20 3475 4226

 

About Microsaic Systems

 

Microsaic Systems develops and sells chip-based scientific instruments for the chemical identification of substances. The Company's products are based on the 'gold-standard' scientific technique of mass spectrometry.

 

Microsaic Systems has developed a miniaturised mass spectrometer based on its patented, chip-based technologies (ionchip®, spraychip® and vac-chip™), that is smaller, lighter, quieter, more energy efficient and cheaper to run than conventional mass spectrometer systems.

 

Mass spectrometry is used across many industry sectors, including government, energy, utilities, pharmaceutical, diagnostics and healthcare, environmental, food and drink, security and defence, and industrial chemicals - a combined market of $3 billion in 2012.

 

Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in April 2011 under the symbol MSYS.

 

www.microsaic.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGGUUUCUPCURA
Date   Source Headline
5th Mar 20197:00 amRNSInvestor Event
19th Feb 20197:00 amRNSNotice of Results
11th Jan 20197:00 amRNSNew Protein Identification Product
19th Dec 201811:20 amRNSBioprocessing partnership update & trading update
7th Nov 20187:00 amRNSExclusive US and Canada Distribution Agreement
3rd Sep 20187:00 amRNSInterim Results
7th Aug 20187:00 amRNSNotice of Results
29th Jun 20184:12 pmRNSHolding(s) in Company
26th Jun 20182:04 pmRNSHolding(s) in Company
25th Jun 201810:10 amRNSDirectors' Interests
22nd Jun 201810:40 amRNSResult of GM, Completion of Fundraising & TVR
21st Jun 20187:00 amRNSDistribution Agreement with Amedis, spol. s ro.
13th Jun 20187:00 amRNSDistribution Agreement with Omicron Research Ltd.
6th Jun 20187:00 amRNSSuccessful Fundraising of £5.5 million
5th Jun 20184:46 pmRNSPrimaryBid.com Offer
5th Jun 20184:45 pmRNSFundraising
24th May 20187:00 amRNSDistribution Agreement with Stable Arm Sdn. Bhd.
9th May 20187:00 amRNSAgreement with Rightek Co., Ltd.
4th May 201811:25 amRNSResult of AGM
4th May 20187:00 amRNSAGM Statement
12th Apr 20187:00 amRNSMicrosaic signs Agreement with Knauer
6th Apr 20187:00 amRNSNotice of AGM and Posting of Annual Report
28th Mar 20187:00 amRNSAgreement with Unimicro Technologies Inc.
23rd Mar 20184:45 pmRNSHolding(s) in Company
21st Mar 20187:00 amRNSCommercial contract with CPI Innovation Services
5th Mar 20187:00 amRNSFinal Results
21st Feb 20187:00 amRNSNotice of Results
3rd Jan 20187:00 amRNSAward of Options
19th Dec 20177:00 amRNSDirectorate Change
13th Dec 20177:00 amRNSResearch agreement with global biopharma partner
28th Sep 20177:00 amRNSInterim Results
25th Sep 20177:00 amRNSAppointment of CEO
13th Sep 20177:00 amRNSMicrosaic to Exhibit at BioProcess International
14th Aug 20177:00 amRNSNotice of Results
19th Jun 20177:00 amRNSTrading Statement
15th May 201711:42 amRNSResult of AGM
11th May 20177:00 amRNSMicrosaic Enhances Bioprocessing Capabilities
26th Apr 20177:00 amRNSIntegration with SCPA chromatography software
21st Apr 20177:00 amRNSNotice of AGM
7th Apr 20177:00 amRNSAgreement
21st Mar 20177:00 amRNSFinal Results
13th Mar 20177:00 amRNSChange of registrar
24th Jan 201712:56 pmRNSAppointment of Interim Chairman
13th Dec 20167:00 amRNSTrading Statement
28th Sep 20167:00 amRNSDirectorate Change
21st Sep 20164:39 pmRNSHolding(s) in Company
16th Sep 20161:44 pmRNSDirector/PDMR Shareholding
15th Sep 20161:03 pmRNSHolding(s) in Company
15th Sep 201610:02 amRNSTR-1: Notification of Major Interest in Shares
14th Sep 20165:23 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.